TVTX
Travere Therapeutics Inc
NASDAQ: TVTX · HEALTHCARE · BIOTECHNOLOGY
$40.10
-1.93% today
Updated 2026-04-29
Market cap
$3.70B
P/E ratio
—
P/S ratio
7.55x
EPS (TTM)
$-0.57
Dividend yield
—
52W range
$14 – $43
Volume
1.9M
Travere Therapeutics Inc (TVTX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |